cancer

Wealthier women living in communities with larger income gaps are most likely to get a test that can help determine the best way to treat early-stage breast cancer.

Dr. Dennis Slamon, director of the Revlon/UCLA Women’s Cancer Research Program and director of clinical and translational research at the Jonsson Cancer Center, will appear in a three-part, six-hour series on PBS, "Cancer: The Emperor of All Maladies."

New treatment platform may solve some of the problems of treating pancreas cancer with chemotherapy.

The combination of two cancer-targeted therapies and immunotherapy helps a person’s immune system attack cancerous tumors and does so with fewer side effects.

A series of mental training exercises has been shown to help mitigate the effects of “chemo brain,” which affects up to 35 percent of women after their treatments for breast cancer.

The doctors developed a predictive “calculator” called a nomogram after analyzing 30 years’ worth of data from liver transplants for people with liver cancer.

On March 9, Apple announced the launch of Share the Journey, a mobile app that UCLA’s Dr. Patricia Ganz helped develop.

Funding from the Hirshberg Foundation has elevated the UCLA center to one of the nation’s premier comprehensive programs for pancreatic cancer and diseases.

Radiation therapy is the most common treatment for men with prostate cancer, but it may not always be worthwhile.

UCLA bioengineers have developed a revolutionary approach that brings together traditional drugs and nanotechnology-enhanced medications to create safer and more effective treatments.

Jillian Neuner raised $1,750 for UCLA research in honor of a friend battling Ewing's Sarcoma, one of the rarest forms of pediatric cancer.

Research at UCLA played key role in developing the treatment, which could signal a new strategy for arresting tumor growth and extending the time before cancer worsens.

The discovery by scientists at the UCLA Jonsson Comprehensive Cancer Center paves the way for the development of more effective patient-tailored therapies.

Less than a third of parents reported that their child wore a hat or sunglasses or attempted to seek shade when exposed to the sun.

A team led by researchers at the California NanoSystems Institute developed a new method for extracting and analyzing cancer cells circulating in patients’ blood.

UCLA study shows that combining palbociclib with letrozole effectively doubled the length of time women with estrogen receptor-positive breast cancer were on treatment without their cancer worsening.

UCLA researchers led by Aydogan Ozcan have developed a lens-free microscope that can be used to detect cancer with the same accuracy as larger and more expensive optical microscopes.

UCLA’s Edward Garon, the study’s principal investigator, says the drug offers new hope for people with lung cancer who often have few treatment options.

Unlike current surgical methods, the technique is minimally invasive with few side effects and does not require chemotherapy or radiation.

Logan Nobriga, a 10-year-old-boy who is battling cancer, was honored at a Bruins’ basketball game as the first “Kid Captain” selected by Mattel Children’s Hospital UCLA and the UCLA Men’s Basketball team.

National guidelines recommend that men in these cases should not be treated with radiation or surgery, since they are unlikely to live long enough to benefit from treatment.

The findings will help physicians determine the best treatment for patients most likely to respond to the drug and develop new combination treatments for melanoma and other cancers.

New research provides a better understanding of how osteonecrosis of the jaw progresses and could guide the development of therapeutic and preventive measures.

UCLA School of Dentistry researchers show that electric field-induced release and measurement is a reliable way to detect tumor-causing mutations that would be more cost-effective and efficient.

Michael Eselun, certified interfaith chaplain for the Simms/Mann UCLA Center for Integrative Oncology, explores "It could be worse," a common coping strategy for dealing with cancer.